Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/103766
Title: Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer's Disease Agents
Authors: Poliseno, Viviana
Chaves, Sílvia
Brunetti, Leonardo
Loiodice, Fulvio
Carrieri, Antonio
Laghezza, Antonio
Tortorella, Paolo
Magalhães, João D. 
Cardoso, Sandra M. 
Santos, M. Amélia 
Piemontese, Luca
Keywords: Alzheimer’s disease; tenuazonic acid; donepezil; neurodegenerative; metal chelation; multifunctional drugs; acetylcholinesterase; antioxidant; amyloid
Issue Date: 15-Jan-2021
Publisher: MDPI AG
Project: Università degli Studi di Bari “Aldo Moro” and Regione Puglia (Fondo di Sviluppo e Coesione 2007–2013, APQ Ricerca Regione Puglia “Programma regionale a sostegno della specializzazione intelligente e della sostenibilità sociale ed ambientale— FutureInResearch”—Project ID: I2PCTF6) 
UID/QUI/00100/2019 
POCI-01-0145-FEDER-030712 
Serial title, monograph or event: Biomolecules
Volume: 11
Issue: 1
Abstract: Alzheimer's disease (AD) is generally recognized as a multifactorial neurodegenerative pathology with an increasing impact on society. Tenuazonic acid (TA) is a natural compound that was recently identified as a potential multitarget ligand with anti-cholinesterase, anti-amyloidogenic and antioxidant activities. Using its structure as a chemical scaffold, we synthesized and evaluated new derivatives (1-5), including tenuazonic-donepezil (TA-DNP) hybrids (4 and 5) due to the clinical importance of the anti-AD drug donepezil. These novel compounds all achieved activity in the micromolar range towards all selected targets and demonstrated to be potentially orally absorbed. Moreover, a selected compound (1) was further investigated as a chelating agent towards copper (II), zinc (II) and iron (III) and showed good chelating ability (pFe = 16.6, pCu = 11.6, pZn = 6.0 at pH 7.4). Therefore, the TA motif can be considered an interesting building block in the search for innovative multi-functional anti-neurodegenerative drugs, as exemplified by hybrid 5, a promising non-cytotoxic lead compound adequate for the early stages of AD, and capable of ameliorating the oxidative status of SH-SY5Y human neuroblastoma cells.
URI: https://hdl.handle.net/10316/103766
ISSN: 2218-273X
DOI: 10.3390/biom11010111
Rights: openAccess
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais
FMUC Medicina - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
biomolecules-11-00111-v2.pdf4.74 MBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

10
checked on May 2, 2023

Page view(s)

61
checked on Jul 17, 2024

Download(s)

27
checked on Jul 17, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons